MWA
ABBV icon

Meridian Wealth Advisors’s AbbVie ABBV Stock Holding History

Meridian Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378K Buy
1,502
+14
+0.9% +$3.01K 0.04% 161
2026
Q1 		$324K Buy
1,488
+146
+11% +$32.4K 0.04% 157
2025
Q4 		$307K Sell
1,342
-451
-25% -$103K 0.04% 151
2025
Q3 		$415K Buy
1,793
+413
+30% +$84.1K 0.06% 135
2025
Q2 		$256K Buy
1,380
+1
+0.1% +$186 0.04% 158
2025
Q1 		$289K Sell
1,379
-8
-0.6% -$1.55K 0.05% 148
2024
Q4 		$246K Sell
1,387
-117
-8% -$21.5K 0.04% 159
2024
Q3 		$297K Sell
1,504
-70
-4% -$13.1K 0.05% 151
2024
Q2 		$270K Buy
1,574
+80
+5% +$13.3K 0.05% 153
2024
Q1 		$272K Hold
1,494
– – 0.05% 154
2023
Q4 		$232K Hold
1,494
– – 0.05% 162
2023
Q3 		$223K Hold
1,494
– – 0.06% 164
2023
Q2 		$201K Hold
1,494
– – 0.05% 176
2023
Q1 		$238K Hold
1,494
– – 0.06% 167
2022
Q4 		$241K Sell
1,494
-267
-15% -$40.9K 0.06% 166
2022
Q3 		$236K Hold
1,761
– – 0.07% 166
2022
Q2 		$270K Sell
1,761
-215
-11% -$32.9K 0.07% 165
2022
Q1 		$320K Buy
1,976
+410
+26% +$59.6K 0.07% 161
2021
Q4 		$212K Buy
+1,566
New +$185K 0.05% 186
2019
Q2 		– Sell
-5,211
Closed -$420K – 131
2019
Q1 		$420K Buy
5,211
+145
+3% +$11.9K 0.31% 70
2018
Q4 		$467K Buy
+5,066
New +$446K 0.36% 54

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Meridian Wealth Advisors's ABBV Position: Q2 2026 in Review

Meridian Wealth Advisors increased its AbbVie (ABBV) stake by 0.94% in Q2 2026, buying an estimated $3.01K and bringing the position to 1,502 shares worth $378K. The position accounts for 0.04% of the portfolio, ranked #161.

Meridian Wealth Advisors first reported a position in ABBV in Q4 2018 and has held it in 21 quarters since. The position peaked at $467K in Q4 2018. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Meridian Wealth Advisors held 1,502 shares of AbbVie worth $378K as of Q2 2026.
  • Meridian Wealth Advisors bought 14 AbbVie shares in Q2 2026, an estimated $3.01K.
  • AbbVie made up 0.04% of Meridian Wealth Advisors's portfolio in Q2 2026, its #161 holding.
  • Meridian Wealth Advisors first reported a position in AbbVie in Q4 2018 and has held it in 21 quarters since.
  • Meridian Wealth Advisors's AbbVie position peaked at $467K in Q4 2018.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.